SCHEMBL7236532

SCHEMBL7236532

Cc1c(C)c(N(Cc2ccccc2)C(=O)O)c(C)c(C)c1O

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSPO P30536 1/20 0.47
TRPM8 Q7Z2W7 1/20 0.46
LMNA P02545 1/20 0.46
NPC1 O15118 4/20 0.44
RAB9A P51151 4/20 0.44
ALDH1A1 P00352 2/20 0.44
HTT P42858 2/20 0.44
PAX8 Q06710 2/20 0.44
GLA P06280 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
CA12 O43570 1/20 0.43
CA9 Q16790 1/20 0.43
POLB P06746 1/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
JAK2 O60674 1/20 0.42
TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1925384 0.79 TRPM8 (0.57) TSPOTRPM8LMNANPC1RAB9A
SCHEMBL1927316 0.71 TDP1 (0.57) TSPOTRPM8NPC1RAB9AALDH1A1
SCHEMBL1927016 0.71 ALDH1A1 (0.69) TSPOTRPM8NPC1RAB9AALDH1A1
SCHEMBL1926093 0.69 TSHR (0.51) TSPOTRPM8NPC1RAB9AALDH1A1
SCHEMBL1259310 0.69 PDK1 (0.58) TRPM8NPC1RAB9AALDH1A1HTT
SCHEMBL29009652 0.69 TSHR (0.49) TSPOTRPM8NPC1RAB9AKMT2A
SCHEMBL2457272 0.69 PDK1 (0.54) TSPOTRPM8NPC1RAB9AALDH1A1
SCHEMBL6647621 0.68 LMNA (0.57) LMNANPC1RAB9AALDH1A1HTT
SCHEMBL16435054 0.68 KMT2A (0.44) TSPOTRPM8NPC1RAB9AALDH1A1
SCHEMBL4237595 0.68 CNR2 (0.58) TSPONPC1RAB9AALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030139447-A1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof ASUBIO PHARMA CO., LTD. (JP) 2003-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030139447-A1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof SCN10A, CAMK2A, CAMK2B TSPO 1662/4885TRPM8 1328/4885LMNA 3529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.